2 FDA committee members resign over Biogen Alzheimer's drug approval
June 11 2021, 08:00
Fallout over the FDA’s recent decision to grant Biogen’s Alzheimer’s drug accelerated approval has seen two advisory panel members resign.
Fallout over the FDA’s recent decision to grant Biogen’s Alzheimer’s drug accelerated approval has seen two advisory panel members resign.
Source:
FOX News